The clinical utility of apoB versus LDL-C/non-HDL-C

Kohli-Lynch, CN; Thanassoulis, G; Moran, AE; Sniderman, AD

Sniderman, AD (corresponding author), McGill Univ, Mike & Valeria Rosenbloom Ctr Cardiovasc Prevent, Div Cardiol, Royal Victoria Hosp,Hlth Ctr, 1001 Decarie Blvd, Montreal, PQ, Canada.

CLINICA CHIMICA ACTA, 2020; 508 (): 103

Abstract

Background: The ESC/EAS Guidelines and the EAS/EFLM consensus reports state that apoB is a more accurate marker of cardiovascular risk than LDL-C or n......

Full Text Link